{"ticker": {"uuid": "5906186f-1b27-4bc0-8255-925de85a8526", "symbol": "APS", "name": "Aptose Biosciences Inc.", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Aptose reports 86% response rate in AML triplet therapy trial By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQN1d0Sk5jdlB3SkctanI4QUxRSWJYQzVVS196eHJOR3kzc3JNZUhSYWg5LVV0bENPUzU5MWN5aUdGSmdaR1RLRnVjUXI3YnRhZDI1UllRUUY2dzdLX3FZZ2ljRFdQZVQ3QzBqNGJ6WFRXN0FxSlBRSFl2b3dLQVlzYlhyZ0VrZFMyUmVjUUxocEMtVjd4WE0tOFFxcmFpeWFRSlBSd2dsR0ktUzlIYmNCVjNXaTNiUzNfaGFNWlln?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-15T11:41:39+00:00", "published_display": "15 Jun 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Update on Anticipated Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPY3hQaXY5NzZPQjZ1Um04YXlOdVVhZU5YVllHbXZKbFFpUzNRN0NWNnlTWEFBdDdJU0pqU0ppbTRVcWxONmx2OThheVJONk1DbTdIZ3ZnT3pveEMybDNIT3JwUEY4M2g4RTkxTUVrZkI1WVJfNENRblU5SWdDS1hTRGhrbXZaeXQ3ZlNPbVROcUNIV051N29fa2lSTGpoaGR0bThoVzE2dlVQQjFkT1FicldKRlZJSF9fTG8yN2dMUnhHbFd2R3ltQjk0Mk1teU9YVVdONjlEdVBWaUhBM3IwTlBSS3liZzc5N2JMTmJ2akdpNmZKZjV1X1YyZUVTU1RZcjczeHN6cGN3eTNNV3ZqWXlrMU1kSVRZTHJGRHNJNVd0UU0?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Results of Special", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Amendment to Arrangement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogJBVV95cUxPdE1ONktyVDNSX29OVzhBUjRSQ0VvXy11Nnp4bUlaanZkSTZaSk52eXVrTlRXd1dXbElGNEJzelpTc3M5U1ZVRTh6NjJza1ZUdmlyNlh3c3RmaFZsbEZiZHZlSVMwbk9VRTRjd2IwY3VMMW1tWGhuUnYtZ2xYLWVhekdzWG5JbnJvWEI2UFliTEw3NXVMa2JDZUdsOUhDcFZkWGdfajdHT2pLMFp2V3BETmc3VkdkZThWTllhdExzdkRpMy1jd1Y5a01KS09CTjI5N3otd3lRSTZuSFlUemdVY1dsRnByR291cnVtZTBnTUxXYmVJT2VHWmJXTDdLNG55eVBZT1h2ZkdqbkI0MGlQT1hoQmhlN3NjekVTcm12RzN5UQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Reports Third Quarter 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOajZ2WXFOTElZanJLa1BsTERHSzVjVWtzQnhxSzJMRGZkWXVna2RBUGVnUF9wNWl5dEd1U3BMQTlOdmc3VjV3M1kwdFFIeWtWU3NMY3llZTVLNUxxX0trTjk1RUNGWjl0S0J4SE9EbHBtOG9QbHRNVzhYZV9tYk85d1BXbTdBN2VQd2RtTmFSQzc0LVJ0ejdkS0RQMXdORV9jd3ZUbjJfbGNTa0lIUUpRMXZ2U2stUlh0?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences (APS) Stock Price, News & Analysis $APS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1SX3VvbEZsWE13Q1AwcXBXNWFNYkFGRnlSd2pyR0hoY05PUDNabVdmeG81Z0I5N0xFQkxCY2hHdDFPWnQ0TDlFem9rcGtMRnVpZkY1cQ?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-18T08:57:44+00:00", "published_display": "18 Aug 2016 08:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences (APTO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFA3TmhSQXhkZGt5SFBUYzFJX3FiOS1YWngwemVOOEFwdlVZNm43eUFJSVpoUi1BUzlCT0FrQWlHZXRfZnJselkxQ0VmNWlSRVQ4V1FmUktRdmZxdw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T10:43:47+00:00", "published_display": "12 Aug 2016 10:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Aptose reports 86% response rate in AML triplet therapy trial By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQN1d0Sk5jdlB3SkctanI4QUxRSWJYQzVVS196eHJOR3kzc3JNZUhSYWg5LVV0bENPUzU5MWN5aUdGSmdaR1RLRnVjUXI3YnRhZDI1UllRUUY2dzdLX3FZZ2ljRFdQZVQ3QzBqNGJ6WFRXN0FxSlBRSFl2b3dLQVlzYlhyZ0VrZFMyUmVjUUxocEMtVjd4WE0tOFFxcmFpeWFRSlBSd2dsR0ktUzlIYmNCVjNXaTNiUzNfaGFNWlln?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-15T11:41:39+00:00", "published_display": "15 Jun 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Update on Anticipated Timing", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowJBVV95cUxPY3hQaXY5NzZPQjZ1Um04YXlOdVVhZU5YVllHbXZKbFFpUzNRN0NWNnlTWEFBdDdJU0pqU0ppbTRVcWxONmx2OThheVJONk1DbTdIZ3ZnT3pveEMybDNIT3JwUEY4M2g4RTkxTUVrZkI1WVJfNENRblU5SWdDS1hTRGhrbXZaeXQ3ZlNPbVROcUNIV051N29fa2lSTGpoaGR0bThoVzE2dlVQQjFkT1FicldKRlZJSF9fTG8yN2dMUnhHbFd2R3ltQjk0Mk1teU9YVVdONjlEdVBWaUhBM3IwTlBSS3liZzc5N2JMTmJ2akdpNmZKZjV1X1YyZUVTU1RZcjczeHN6cGN3eTNNV3ZqWXlrMU1kSVRZTHJGRHNJNVd0UU0?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Results of Special", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences Announces Amendment to Arrangement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogJBVV95cUxPdE1ONktyVDNSX29OVzhBUjRSQ0VvXy11Nnp4bUlaanZkSTZaSk52eXVrTlRXd1dXbElGNEJzelpTc3M5U1ZVRTh6NjJza1ZUdmlyNlh3c3RmaFZsbEZiZHZlSVMwbk9VRTRjd2IwY3VMMW1tWGhuUnYtZ2xYLWVhekdzWG5JbnJvWEI2UFliTEw3NXVMa2JDZUdsOUhDcFZkWGdfajdHT2pLMFp2V3BETmc3VkdkZThWTllhdExzdkRpMy1jd1Y5a01KS09CTjI5N3otd3lRSTZuSFlUemdVY1dsRnByR291cnVtZTBnTUxXYmVJT2VHWmJXTDdLNG55eVBZT1h2ZkdqbkI0MGlQT1hoQmhlN3NjekVTcm12RzN5UQ?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Reports Third Quarter 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOajZ2WXFOTElZanJLa1BsTERHSzVjVWtzQnhxSzJMRGZkWXVna2RBUGVnUF9wNWl5dEd1U3BMQTlOdmc3VjV3M1kwdFFIeWtWU3NMY3llZTVLNUxxX0trTjk1RUNGWjl0S0J4SE9EbHBtOG9QbHRNVzhYZV9tYk85d1BXbTdBN2VQd2RtTmFSQzc0LVJ0ejdkS0RQMXdORV9jd3ZUbjJfbGNTa0lIUUpRMXZ2U2stUlh0?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences (APS) Stock Price, News & Analysis $APS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1SX3VvbEZsWE13Q1AwcXBXNWFNYkFGRnlSd2pyR0hoY05PUDNabVdmeG81Z0I5N0xFQkxCY2hHdDFPWnQ0TDlFem9rcGtMRnVpZkY1cQ?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-18T08:57:44+00:00", "published_display": "18 Aug 2016 08:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptose Biosciences (APTO) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFA3TmhSQXhkZGt5SFBUYzFJX3FiOS1YWngwemVOOEFwdlVZNm43eUFJSVpoUi1BUzlCT0FrQWlHZXRfZnJselkxQ0VmNWlSRVQ4V1FmUktRdmZxdw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T10:43:47+00:00", "published_display": "12 Aug 2016 10:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 7, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 7, "score": 50, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2.2, "latest_week": "2026-06-19", "one_week_move": 0.5, "four_week_move": -7.6, "twelve_week_move": -2.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.863122, "market_dynamics_buy_signal": false, "relative_strength": -3.56784, "fair_value_gap": -2.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 35.0739, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.5% over one week, -7.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GlobeNewswire", "count": 4}, {"label": "MarketBeat", "count": 2}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.5% over one week, -7.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Aptose reports 86% response rate in AML triplet therapy trial By Investing.com"}], "updated_at": "2026-06-22T11:25:44.063211+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}